We currently don't have sufficient analyst coverage to forecast growth and revenue for Merck.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth
14.8%
Revenue growth rate
n/a
Future return on equity
n/a
Analyst coverage
None
Last updated
n/a
Recent future growth updates
No updates
Recent updates
In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Merck has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
IDX:MERK - Analysts future estimates and past financials data (IDR Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
3/31/2026
1,268,611
295,882
420,180
440,197
N/A
12/31/2025
1,200,667
243,896
360,646
376,518
N/A
9/30/2025
1,097,120
178,505
182,956
206,943
N/A
6/30/2025
1,045,699
128,776
168,028
189,225
N/A
3/31/2025
1,002,413
143,003
55,618
72,711
N/A
12/31/2024
1,036,748
153,463
38,880
55,712
N/A
9/30/2024
934,621
124,907
69,353
81,041
N/A
6/30/2024
934,432
134,074
116,574
135,404
N/A
3/31/2024
949,799
155,585
131,055
146,137
N/A
12/31/2023
961,434
178,240
183,972
203,875
N/A
9/30/2023
1,035,913
160,481
203,129
228,401
N/A
6/30/2023
1,023,241
147,802
140,083
153,125
N/A
3/31/2023
1,084,164
163,535
104,196
124,723
N/A
12/31/2022
1,124,600
179,838
90,138
110,323
N/A
9/30/2022
1,147,548
163,618
-3,237
25,898
N/A
6/30/2022
1,157,128
173,520
69,510
97,903
N/A
3/31/2022
1,112,601
140,958
125,812
156,562
N/A
12/31/2021
1,064,395
131,661
126,723
169,815
N/A
9/30/2021
1,002,110
134,624
211,868
252,830
N/A
6/30/2021
879,843
121,326
202,299
253,239
N/A
3/31/2021
746,960
90,227
116,296
161,868
N/A
12/31/2020
655,847
71,902
40,559
71,983
N/A
9/30/2020
686,477
116,256
60,400
79,243
N/A
6/30/2020
710,680
104,255
16,212
33,205
N/A
3/31/2020
743,720
101,692
-238,483
-218,373
N/A
12/31/2019
744,635
78,257
N/A
-210,844
N/A
9/30/2019
649,092
-1,407
N/A
-264,172
N/A
6/30/2019
633,302
13,257
N/A
-314,050
N/A
3/31/2019
633,747
28,904
N/A
136,796
N/A
12/31/2018
611,958
37,378
N/A
168,965
N/A
9/30/2018
144,570
-65,656
N/A
227,960
N/A
6/30/2018
270,973
-40,950
N/A
292,212
N/A
3/31/2018
407,044
-16,297
N/A
206,199
N/A
12/31/2017
582,002
29,455
N/A
129,920
N/A
9/30/2017
1,125,749
179,358
N/A
107,500
N/A
6/30/2017
1,063,319
157,481
N/A
154,775
N/A
3/31/2017
1,045,176
159,314
N/A
-10,282
N/A
12/31/2016
1,034,807
153,843
N/A
43,799
N/A
9/30/2016
1,036,484
146,492
N/A
63,040
N/A
6/30/2016
1,031,758
149,614
N/A
38,701
N/A
3/31/2016
1,018,683
152,613
N/A
193,054
N/A
12/31/2015
983,446
142,545
N/A
160,700
N/A
9/30/2015
976,678
155,763
N/A
136,720
N/A
6/30/2015
963,813
165,213
N/A
255,216
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if MERK's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if MERK's earnings are forecast to grow faster than the ID market
High Growth Earnings: Insufficient data to determine if MERK's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if MERK's revenue is forecast to grow faster than the ID market.
High Growth Revenue: Insufficient data to determine if MERK's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if MERK's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/29 17:19
End of Day Share Price
2026/05/29 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PT Merck Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.